4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-14-002064
CEO acquired 268,653 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEWIS JONATHAN CEO | 2014-01-06 | Option exercise | +25,674 | $0.08 | $2,054 | 535,427 | D |
| LEWIS JONATHAN CEO | 2014-01-06 | Option exercise | +242,979 | $0.08 | $19,438 | 778,406 | D |
| Derivatives | |||||||
| LEWIS JONATHAN CEO | 2014-01-06 | Option exercise · Stock Option (right to buy) | −25,674 | 0 | D | ||
| LEWIS JONATHAN CEO | 2014-01-06 | Option exercise · Stock Option (right to buy) | −242,979 | 0 | D | ||
Loading xslF345X03/doc4.xml…